The mechanism of action (MOA) of a drug means identifying which proteins it binds to, and the mode of action (MoA) means knowing which pathways the drug affects.
Understanding the mechanism of action of a drug entails identifying which proteins it binds to, while understanding the mode of action means knowing which pathways the drug affects and, consequently, its impact (e.g., a drug with an anti-inflammatory function).
From phenotype to pathway
Exploring the mechanism and/or mode of action of a drug usually involves first noticing a phenotype or phenomenon, and then exploring which pathways are responsible for such observation. A key step on deciphering the mode of action, is understanding the sequence of effects, to be able to pinpoint all the potential pathways affected, and potential outcomes. Common ways for analyzing this, are by performing transcriptomic and proteomic analysis, amongst other types of omics studies.
If you are looking for the ideal in vivo preclinical model to understand the MOA and MoA of your construct, genOway can help you with the next steps.

Having comprehensive background information is essential for selecting the right model for your research needs. Understanding your drug target and its expression profile allows us to recommend the most suitable model aligned with your needs. You can contact us and talk with our scientific experts—we will be happy to discuss your data to ensure that we provide you with the most appropriate model for your research.
To help you choose the best model for dissecting the mechanism/mode of action of your compound, we may ask you some of the following questions:
Selecting the right preclinical model is essential for a successful transition to clinical trials. It ensures your results are relevant to human biology and helps avoid costly delays. Choosing the wrong model for your studies may lead to pinpointing the wrong pathway as the mechanism responsible for the physiological event you observe.
We offer a diverse portfolio of translational preclinical models designed to support your research goals. These models can be used independently or in combination to enhance and accelerate your studies. They are available off the shelf through our Catalog Models, or can be custom developed to meet your specific requirements through our Customized Models.

Our selection of catalog models includes different types of models useful for MoA assessment.
A wide range of target-specific humanized strains is available and ready for purchase. These models are immunocompetent, and display a physiological expression of the human target. Some of the models present in our catalog include:
If you are aiming to understand how your drug works within the context of a tumor, our humanized mouse models can be used for syngeneic studies, for which there is available a complementary catalog of cell lines.
As part of our catalog, we also provide humanized mouse models with a human immune system (HIS), such as the genO-BRGSF-HIS and genO-BRGSF-A2-HIS models. Given their extended lifespan, functional human myeloid and lymphoid compartments, and permissiveness to PDX and CDX engraftments, these models are ideal for the translational understanding of the MoA or MOA of a therapeutic in the context of human tumors, such as understanding how it might polarize cells within the tumor microenvironment, or lead to the recruitment of cytotoxic cells (AACR 2025 poster).
In our vast portfolio, you can also find immunodeficient rodents. If you are trying to understand the contribution of the immune system in the effect of your compound, then our immunodeficient models can be useful to you. They also support PDX and CDX engraftment if you want to perform your analysis in the context of a tumor, as well as allow longer experimental timeframes due to their extended longevity.
If you are looking for a unique model that is not part of our portfolio, we can also make a customized model for you. Our scientists will consider all of your needs and create the best model to fit your research. You can easily book a discussion session and we will guide you through the process.
We work alongside you as research partners, offering guidance at every stage of your project — from planning and experiment design to data analysis. Our experienced scientists are available to collaborate closely with you, ensuring your studies are carefully structured and optimized for success. More than just advisors, we are dedicated to advancing your research and helping you achieve the strongest outcomes possible.
You can contact us at any moment during the process — we are here to help and willingly dedicate time to you and to your needs.

If you don’t have the time or facilities to run your first proof-of-concept studies, we can support you by conducting them on our preclinical platform at genOway or at a Contract Research Organization (CRO). Depending on your scientific needs and on the model of choice, genOway can connect you with a trusted CRO to manage the work, allowing you to focus on driving your research forward.

From model design to experimental results
Featured in 600+ scientific articles
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Generated with biopharma partners and in-house
and guaranteed freedom to operate
Models with certified health status from professional breeders in US and Europe